Home › Companies › IVERIC BIO INC. › 2023-2024
Compiled from SEC Form N-PX filings and IVERIC BIO INC.’s Form 8-K, filed 2023-07-06 (Item 5.07 on EDGAR). Page generated 04 October 2026.
Proxy season: 2023-2024
Explore IVERIC BIO INC. in the interactive database Compare manager voting policies
These tallies are IVERIC BIO INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2023-07-06 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Proposal 1: The Merger Proposal | 109,590,295 | 94,590 | 458,429 | -- | 0 | Majority: yes |
| Proposal 2: The Compensation Proposal | 79,668,097 | 29,241,961 | 1,233,256 | -- | 0 | Majority: yes |
| Proposal 3: The Adjournment Proposal | 101,361,184 | 8,291,820 | 490,310 | -- | 0 | Majority: yes |
Source: IVERIC BIO INC., Form 8-K, filed with the SEC on 2023-07-06 — read the filing on EDGAR.
Each item below shows how the 270 asset managers that disclosed a IVERIC BIO INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of IVERIC BIO INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 9 wordings of this item as funds reported it.
68% fund support · no official result
The 257 asset managers below cast 68% of the shares they voted on this item FOR (78,786,760 for, 37,395,149 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 13,598,525 | 0 | 0 | Against |
| BlackRock | 9,523,133 | 51,108 | 0 | 0 | For |
| Avoro Capital Advisors LLC | 8,500,000 | 0 | 0 | 0 | For |
| State Street | 7,967,035 | 0 | 0 | 0 | For |
| Man Group plc | 0 | 7,068,940 | 0 | 0 | Against |
| Invesco | 3,723,492 | 0 | 0 | 0 | For |
| UBS | 2,893,531 | 344,120 | 0 | 0 | For |
| FARALLON CAPITAL MANAGEMENT LLC | 3,134,799 | 0 | 0 | 0 | For |
| Fidelity | 2,642,795 | 10,572 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 2,620,632 | 0 | 0 | 0 | For |
| AllianceBernstein | 0 | 2,590,218 | 0 | 0 | Against |
| TIG Advisors, LLC | 2,167,886 | 0 | 0 | 0 | For |
| Segantii Capital Management Ltd | 2,085,000 | 0 | 0 | 0 | For |
| Meeder Advisory Services, Inc. | 2,000,000 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 1,979,519 | 0 | 0 | Against |
| BRAIDWELL LP | 1,802,799 | 0 | 0 | 0 | For |
| BALYASNY ASSET MANAGEMENT L.P. | 0 | 1,583,715 | 0 | 0 | Against |
| MERGER FUND | 1,302,908 | 0 | 0 | 0 | For |
| Nuveen | 1,647 | 1,248,746 | 0 | 0 | Against |
| Deep Track Capital, LP | 1,231,826 | 0 | 0 | 0 | For |
| MPM BioImpact LLC | 1,214,662 | 0 | 0 | 0 | For |
| Dimensional | 0 | 1,162,544 | 0 | 0 | Against |
| Soleus Capital Management, L.P. | 1,140,943 | 0 | 14,100 | 0 | For |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 0 | 1,153,000 | 0 | 0 | Against |
| Redmile Group, LLC | 0 | 1,111,111 | 0 | 0 | Against |
Showing the 25 largest of 257 asset managers. See all 257 in the interactive database.
Combines 4 wordings of this item as funds reported it.
100% fund support · no official result
The 90 asset managers below cast 100% of the shares they voted on this item FOR (42,192,547 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,237,271 | 0 | 0 | 0 | For |
| BlackRock | 5,736,791 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 3,661,747 | 0 | 0 | 0 | For |
| State Street | 2,778,367 | 0 | 0 | 0 | For |
| Fidelity | 2,621,322 | 0 | 0 | 0 | For |
| Invesco | 1,716,784 | 0 | 0 | 0 | For |
| MERGER FUND | 1,302,908 | 0 | 0 | 0 | For |
| TIAA | 1,027,249 | 0 | 0 | 0 | For |
| Dimensional | 1,003,201 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 999,058 | 0 | 0 | 0 | For |
| Charles Schwab | 981,748 | 0 | 0 | 0 | For |
| AllianceBernstein | 555,222 | 0 | 0 | 0 | For |
| Federated Hermes | 0 | 0 | 450,000 | 0 | Abstain |
| Equitable | 447,534 | 0 | 0 | 0 | For |
| American Century | 421,389 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 383,600 | 0 | 0 | 0 | For |
| Principal | 336,989 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 315,636 | 0 | 0 | 0 | For |
| TimesSquare Capital Management, LLC | 263,400 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 232,692 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 232,094 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 227,111 | 0 | 0 | 0 | For |
| Jackson National | 226,599 | 0 | 0 | 0 | For |
| Putnam | 203,341 | 0 | 0 | 0 | For |
| ARBITRAGE FUNDS | 180,032 | 0 | 0 | 0 | For |
Showing the 25 largest of 90 asset managers. See all 90 in the interactive database.
Combines 2 wordings of this item as funds reported it.
86% fund support · no official result
The 88 asset managers below cast 86% of the shares they voted on this item FOR (33,945,375 for, 5,453,627 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,237,271 | 0 | 0 | 0 | For |
| BlackRock | 5,736,791 | 0 | 0 | 0 | For |
| State Street | 0 | 2,778,367 | 0 | 0 | Against |
| Fidelity | 99,436 | 2,521,886 | 0 | 0 | Against |
| Invesco | 1,716,784 | 0 | 0 | 0 | For |
| MERGER FUND | 1,302,908 | 0 | 0 | 0 | For |
| TIAA | 1,027,249 | 0 | 0 | 0 | For |
| Dimensional | 1,003,201 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 999,058 | 0 | 0 | 0 | For |
| Charles Schwab | 981,748 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 569,842 | 0 | 0 | 0 | For |
| AllianceBernstein | 555,222 | 0 | 0 | 0 | For |
| Federated Hermes | 450,000 | 0 | 0 | 0 | For |
| Equitable | 447,534 | 0 | 0 | 0 | For |
| American Century | 421,389 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 383,600 | 0 | 0 | 0 | For |
| Principal | 336,989 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 315,636 | 0 | 0 | 0 | For |
| TimesSquare Capital Management, LLC | 263,400 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 232,692 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 232,094 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 227,111 | 0 | 0 | 0 | For |
| Jackson National | 226,599 | 0 | 0 | 0 | For |
| Putnam | 203,341 | 0 | 0 | 0 | For |
| ARBITRAGE FUNDS | 180,032 | 0 | 0 | 0 | For |
Showing the 25 largest of 88 asset managers. See all 88 in the interactive database.
Combines 2 wordings of this item as funds reported it.
95% fund support · no official result
The 4 asset managers below cast 95% of the shares they voted on this item FOR (1,451,365 for, 73,672 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,450,000 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 73,672 | 0 | 0 | Against |
| Desjardins Global Asset Management Inc. | 1,365 | 0 | 0 | 0 | For |
| Taconic Capital Advisors LP | 0 | 0 | 0 | 0 | -- |
Ranked by the number of IVERIC BIO INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 137,249,579 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 9.91% |
| 2 | BlackRock | 6.98% |
| 3 | Avoro Capital Advisors LLC | 6.19% |
| 4 | State Street | 5.80% |
| 5 | Man Group plc | 5.15% |
| 6 | Invesco | 2.71% |
| 7 | UBS | 2.36% |
| 8 | FARALLON CAPITAL MANAGEMENT LLC | 2.28% |
| 9 | Fidelity | 1.93% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 1.91% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Norges Bank | 0.20% | 13F |
Percentages above are of 137,249,579 shares outstanding, as reported by IVERIC BIO INC. on its Form 10-Q dated 2023-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from IVERIC BIO INC.’s 10-Q dated 2023-03-31. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.
At IVERIC BIO INC.'s shareholder meeting held 2023-07-06, in the 2023-2024 proxy season, 270 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,115 separate fund positions. Their filings are grouped here into 4 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. IVERIC BIO INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To approve, by non-binding, advisory vote, compensation that may be paid or become payable by… — the reporting funds cast 68% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.
IVERIC BIO INC. proxy season coverage: 2023-2024 (this page).